id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0246-0005,FDA,FDA-2006-N-0246,Supporting Statement for Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format,Supporting & Related Material,Statement (Supporting and Related Material),2007-08-10T00:00:00Z,2007,8,,,2025-05-22T16:32:44Z,,0,0,09000064804572ff
FDA-2006-N-0246-0004,FDA,FDA-2006-N-0246,Supporting Statement for Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format,Supporting & Related Material,Statement (Supporting and Related Material),2007-08-10T00:00:00Z,2007,8,,,2025-05-22T16:35:04Z,,0,0,09000064804572fe
FDA-2006-N-0246-0003,FDA,FDA-2006-N-0246,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval;
Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format",Notice,Notice of Approval,2007-08-09T04:00:00Z,2007,8,2007-08-10T04:00:00Z,,2025-05-22T16:28:57Z,E7-15614,0,0,09000064804572fd